As a crucial metabolic reprogramming factor, HIF-1α may be involved in the progression of a borderline ovarian tumor to an epithelial ovarian cancer, which entails hypoxia-induced invasiveness and migration [10]. Here, HIF1A is linked to ovarian carcinoma.